scholarly journals Diffuse B-cell lymphoma in a child with HIV infection

Author(s):  
Kh. S. Khaertynov ◽  
V. A. Anokhin ◽  
S. V. Khaliullina ◽  
I. V. Osipova ◽  
V. Yu. Shapiro ◽  
...  

Objective. To describe the case of diffuse B-cell lymphoma in a child with HIV infection.Results. A 16-year-old child with HIV infection and generalized lymphadenopathy was diagnosed with diffuse large B-cell lymphoma, stage III, negative central nervous system. The patient was diagnosed on the basis of the results of immunohistochemical study of biopaths of the tissue of the lymph nodes of the submandibular and right axillary region. The study in order to identify markers of active infection caused by the Epstein-Barr virus, cytomegalovirus and human herpesvirus type 6, made it possible to exclude the active phase of diseases that are the main infectious causes of lymphoproliferative syndrome. At the time of hospitalization, the patient was treated with antiretroviral therapy of the combined drug Eviplera. There was no HIV RNA in the blood, the level of CD4 lymphocytes was 0.4·109/l. The BFM chemotherapy regimen was used, which was accompanied by positive dynamics in the form of normalization of body temperature, reduction in the size of lymph nodes.Conclusion. This case shows that immunohistochemical examination of tissue biopsies of enlarged lymph nodes is of decisive importance in the diagnosis of lymphoma, the main non-infectious cause of lymphoproliferative syndrome in patients with HIV infection.

2021 ◽  
Vol 157 (6) ◽  
pp. 306-307
Author(s):  
Alba Hernández-Gallego ◽  
José-Tomás Navarro ◽  
Gustavo Tapia

2017 ◽  
Vol 114 (36) ◽  
pp. E7441-E7449 ◽  
Author(s):  
Jun Tang ◽  
Darin Salloum ◽  
Brandon Carney ◽  
Christian Brand ◽  
Susanne Kossatz ◽  
...  

Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma in adults. DLBCL exhibits highly aggressive and systemic progression into multiple tissues in patients, particularly in lymph nodes. Whole-body 18F-fluodeoxyglucose positron emission tomography ([18F]FDG-PET) imaging has an essential role in diagnosing DLBCL in the clinic; however, [18F]FDG-PET often faces difficulty in differentiating malignant tissues from certain nonmalignant tissues with high glucose uptake. We have developed a PET imaging strategy for DLBCL that targets poly[ADP ribose] polymerase 1 (PARP1), the expression of which has been found to be much higher in DLBCL than in healthy tissues. In a syngeneic DLBCL mouse model, this PARP1-targeted PET imaging approach allowed us to discriminate between malignant and inflamed lymph nodes, whereas [18F]FDG-PET failed to do so. Our PARP1-targeted PET imaging approach may be an attractive addition to the current PET imaging strategy to differentiate inflammation from malignancy in DLBCL.


2020 ◽  
Vol 21 ◽  
Author(s):  
Waleed K. Al-Darzi ◽  
Aeman Hana ◽  
Marc K. Lahiri ◽  
Carina Dagher ◽  
Joshua C. Greenberg ◽  
...  

2019 ◽  
Vol 64 (4) ◽  
pp. 338
Author(s):  
AngooriGnaneshwar Rao ◽  
SyedaSaba Farheen ◽  
Kolli Amit ◽  
UdayDeshmukh Reddy ◽  
Karanam Aparna ◽  
...  

2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Carolina Trindade Mello Medici ◽  
Geovanne Pedro Mauro ◽  
Lucas Coelho Casimiro ◽  
Eduardo Weltman

Sign in / Sign up

Export Citation Format

Share Document